• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.76% Nasdaq Up0.56%

    More On CMXHF



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    • Income Statement
    • Balance Sheet
    • Cash Flow

    CSL Ltd. (CMXHF)

    -Other OTC
    71.15 0.00(0.00%) Nov 24
    ProfileGet Profile for:
    CSL Ltd.
    45 Poplar Road
    Parkville, VIC 3052
    Australia - Map
    Phone: 61 3 9389 1911
    Fax: 61 3 9389 1434
    Website: http://www.csl.com.au

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    CSL Limited engages in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products in Australia, the United States, Germany, Switzerland, and internationally. The company operates through CSL Behring, bioCSL, and CSL Intellectual Property segments. The CSL Behring segment develops, manufactures, and markets plasma products and recombinants, which are used to treat coagulation disorders, including hemophilia and von Willebrand disease, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders. Its products are also used in cardiac surgery, organ transplantation, and burn treatment, as well as to prevent hemolytic diseases in the newborns. The bioCSL segment manufactures and markets biological products for human use; in-licenses and markets vaccines and prescription pharmaceuticals to treat a range of human medical conditions; and manufactures and markets in vitro diagnostic products. The CSL Intellectual Property segment licenses intellectual property to unrelated third parties. The company also markets a range of vaccines and antivenoms, as well as pharmaceutical products supplied by other manufacturers. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on CSL Ltd.

    Key Executives 
    Mr. Paul R. Perreault BA Psychology, 58
    Chief Exec. Officer, Managing Director, Exec. Director, Member of Innovation & Devel. Committee and Member of Securities & Market Disclosure Committee
    Mr. Gordon Naylor MBA, BEng (Hons), DipCompSc, CPA, 52
    Chief Financial Officer and Pres for Seqirus
    Dr. Andrew Cuthbertson BMedSci, MBBS, Ph.D., FTSE, FAHMS, 60
    Chief Scientific officer and Director of R&D
    Mr. Gregory Boss J.D., BS(Hon), 54
    Exec. VP of Legal, Group Gen. Counsel, Exec. VP of CSL Behring and Gen. Counsel of CSL Behring
    Ms. Laurie Reed BS (Finance), MS (Organizational Development), 51
    Sr. VP of HR
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.